Naratriptan medication is utilized to treat headaches. It diminishes cerebral pains, torment and different indications of headaches, including affectability to light/solid, sickness, and heaving. Brief treatment permits you to return to your ordinary routine and may diminish your requirement for other agony medicines. Naratriptan does not counteract future headaches or decrease how regularly you may get a cerebral pain.

Utilizes for Naratriptan Hydrochloride

Vascular Headaches
Intense treatment of headache assaults with or without aura.1

Not suggested for administration of hemiplegic or basilar headache or for the prophylaxis of headache.

Wellbeing and viability not built up for administration of group headaches.1

Naratriptan Hydrochloride Dosage and Administration

Administration

Oral Administration
Direct orally with liquids.

Measurement
Accessible as naratriptan hydrochloride; measurement is communicated as far as naratriptan.

Grown-ups

Vascular Headaches

Headache

Oral
1 or 2.5 mg as a solitary dose;1 individualize measurements choice, measuring the conceivable advantage (more noteworthy adequacy) and dangers (expanded unfavorable impacts) of the 2.5-mg dosage.

On the off chance that cerebral pain repeats or just an incomplete reaction is accomplished, may rehash measurement once following 4 hours.

Taking after inability to react to the main dosage, reexamine finding of headache preceding organization of a second measurements.

Endorsing Limits

Grown-ups

Vascular Headaches

Headache

Oral

Most extreme 5 mg in any 24-hour time frame.

Security of treating a normal of >4 migraines per 30-day time frame not built up.

Alerts for Naratriptan Hydrochloride
Contraindications

Known or suspected ischemic coronary illness (e.g., angina pectoris, history of MI, recorded quiet ischemia).

Coronary supply route vasospasm (e.g., Prinzmetal variation angina).

Uncontrolled hypertension.

Different genuine fundamental cardiovascular disease.

Cerebrovascular disorders (e.g., stroke disorder, TIAs).

Fringe vascular infection or ischemic inside disease.

Extreme hepatic disability (e.g., Child-Pugh grade C).

Extreme renal weakness (e.g., Clcr ≤15 mL/minute).

Hemiplegic or basilar migraine.

Treatment inside past 24 hours with another 5-HT1 receptor agonist or an ergot alkaloid.1 (See Specific Drugs under Interactions.)

Known excessive touchiness to naratriptan or any fixing in the definition